SCHEMBL20108900

SCHEMBL20108900

O=P(c1ccccc1)(c1ccccc1)c1ccc2cc(-c3c4ccccc4c(-c4ccc5ccc6ccc(-c7ccccn7)nc6c5n4)c4ccccc34)ccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.39
ADORA3 P0DMS8 4/20 0.35
TOP1 P11387 1/20 0.35
DHODH Q02127 1/20 0.34
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
RXFP1 Q9HBX9 3/20 0.34
LMNA P02545 4/20 0.33
NPSR1 Q6W5P4 4/20 0.33
KDM4E B2RXH2 2/20 0.33
TP53 P04637 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33
TSHR P16473 1/20 0.33
KLF5 Q13887 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CYP3A4 P08684 3/20 0.33
CCR1 P32246 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20108853 0.90 TOP1 (0.38) CYP2C9TOP1MEN1KMT2ALMNA
SCHEMBL20108858 0.88 TOP1 (0.38) CYP2C9ADORA3TOP1DHODHTP53
SCHEMBL20108910 0.87 CYP2C9 (0.39) CYP2C9ADORA3TOP1DHODHMEN1
SCHEMBL20108913 0.83 TOP1 (0.35) CYP2C9ADORA3TOP1DHODHMEN1
SCHEMBL20108848 0.82 CCR1 (0.39) CYP2C9TOP1LMNAKDM4ETP53
SCHEMBL17403759 0.80 DHODH (0.40) CYP2C9ADORA3DHODHLMNANPSR1
SCHEMBL20108873 0.79 TOP1 (0.36) CYP2C9TOP1MEN1KMT2ALMNA
SCHEMBL20108892 0.79 TOP1 (0.37) CYP2C9TOP1DHODHLMNAKDM4E
SCHEMBL20108881 0.78 TRPV1 (0.35) CYP2C9TOP1LMNAKDM4ETP53
SCHEMBL20108842 0.78 TOP1 (0.36) CYP2C9TOP1LMNAKDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11155543-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same LG DISPLAY CO., LTD. (KR) 2021-10-26 US disclosed
US-20180118742-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-05-03 US disclosed
US-20180118742-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118742-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME OCIAD2, OCIAD1, PPOX CYP2C9 400/4885ADORA3 1978/4885TOP1 2172/4885
US-11155543-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same OCIAD2, OCIAD1, PPOX CYP2C9 400/4885ADORA3 1978/4885TOP1 2172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.